Metabolic disorders affecting the liver and heart: Therapeutic efficacy of miRNA-based therapies?

Metabolic disorders affecting the liver and heart: Therapeutic efficacy of miRNA-based therapies?

Liver and heart disease are major causes of death worldwide. It is known that metabolic alteration causing type 2 diabetes (T2D) and Nonalcoholic fatty liver (NAFLD) coupled with a derangement in lipid homeostasis, may exacerbate hepatic and cardiovascular diseases. Some pharmacological treatments c...

Full description

Bibliographic Details
Main Authors: Lucia La Sala, Valentina Carlini, Caterina Conte, Maria Belen Macas-Granizo, Elham Afzalpour, Jimmy Martin-Delgado, Marco D’Anzeo, Roberto F.E. Pedretti, Angelo Naselli, Antonio E. Pontiroli, Riccardo Cappato
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Pharmacological Research
Subjects:
ASOs
Heart diseases
Liver dysfunction
MiRNAs
ModRNAs
RNA therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S1043661824000276

Internet

http://www.sciencedirect.com/science/article/pii/S1043661824000276

Similar Items